Francedillaois Alhenc-Gelas

Title: Francedillaois Alhenc-Gelas: Innovator in Nucleic Acid Research

Introduction

Francedillaois Alhenc-Gelas is a notable inventor based in Paris, France. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acids. His work has implications for understanding human health and disease.

Latest Patents

Francedillaois holds a patent for a nucleic acid coding for the human testicular angiotensin-converting enzyme (ACE). The object of this invention is the cloning and sequencing of the nucleic acid coding for the human testicular ACE, as well as the determination of the peptide sequence of this ACE. This patent relates to the use of nucleotide probes capable of hybridizing with all or part of the aforementioned nucleic acid. It also includes the development of polyclonal or monoclonal antibodies that specifically recognize all or part of the peptide sequence. These probes and antibodies can be utilized for methods to detect the messenger RNA coding for the testicular ACE in vitro or the testicular ACE directly.

Career Highlights

Francedillaois is affiliated with the Institut National de la Santé et de la Recherche Médicale, a prominent research institution in France. His work has contributed to advancements in medical research and biotechnology.

Collaborations

He has collaborated with notable colleagues such as Florent Soubrier and Christine Hubert, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Francedillaois Alhenc-Gelas is a distinguished inventor whose work in nucleic acid research has the potential to advance our understanding of human health. His contributions are valuable to the scientific community and have significant implications for future research.